Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Liabilities from Discontinued Operations: 2016-2017

Historic Liabilities from Discontinued Operations for Soleno Therapeutics (SLNO) over the last 2 years, with Dec 2017 value amounting to $225,000.

  • Soleno Therapeutics' Liabilities from Discontinued Operations rose 1448.67% to $1.8 million in Q3 2018 from the same period last year, while for Sep 2018 it was $1.8 million, marking a year-over-year increase of 1448.67%. This contributed to the annual value of $225,000 for FY2017, which is 8.69% down from last year.
  • Soleno Therapeutics' Liabilities from Discontinued Operations amounted to $225,000 in FY2017, which was down 8.69% from $246,400 recorded in FY2016.
  • Soleno Therapeutics' Liabilities from Discontinued Operations' 5-year high stood at $246,400 during FY2016, with a 5-year trough of $225,000 in FY2017.
  • Its 2-year average for Liabilities from Discontinued Operations is $235,700, with a median of $235,700 in 2016.
  • Data for Soleno Therapeutics' Liabilities from Discontinued Operations shows a maximum YoY declined of 8.69% (in 2017) over the last 5 years.
  • Over the past 2 years, Soleno Therapeutics' Liabilities from Discontinued Operations (Yearly) stood at $246,400 in 2016, then fell by 8.69% to $225,000 in 2017.